$DDOG

Top infrastructure software stocks ahead of earnings: BofA Securities

BofA Securities identifies infrastructure software as an attractive sector, highlighting Datadog (DDOG) and Atlassian (TEAM) as top picks. The firm expects AI to drive growth and raised price targets for both. DDOG's security offerings crossed $100M in annual recurring revenue, while TEAM's Cloud revenue growth is a key metric. BofA maintains Buy ratings for both, with new price targets of $335 for DDOG and $252 for TEAM.

Original reporting
Published Oct 26, 2026, 6:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 6:44 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefSector analysis
Primary signal
$DDOG
Bullish
high confidence
Mentioned
$DDOG · $TEAM · $PATH
Relevance
6/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DDOGBullishMed
01

Why it matters

The raised targets for DDOG and TEAM suggest a bullish view on AI‑driven growth, while the lowered target for PATH indicates relative weakness.

02

Market read

Analyst target revisions provide fresh guidance that can influence short‑term trading decisions in the infrastructure‑software space.

03

What to watch

Potential slowdown in enterprise IT spending and macro‑economic headwinds could limit upside.

Relevance 6/10Novelty 6/10Timing: pre‑earnings period

Background

BofA Securities released an infrastructure‑software outlook ahead of Q3 earnings, updating price targets for several companies.

Company-level read

Ticker impact

$DDOGBullishHigh confidence
Context

BofA raised Datadog's price objective to $335, citing faster‑growing observability market and security revenue exceeding $100 M ARR.

Expected impact

likely upward pressure as market prices in the higher target.

Evidence & confidence

The new $335 target reflects stronger AI‑driven demand and security growth, which could attract buying.

$TEAMBullishHigh confidence
Context

BofA lifted Atlassian's price objective to $252 from $210, emphasizing AI‑driven cloud revenue growth and long‑term rerating potential.

Expected impact

likely upward pressure as investors re‑rate the stock.

Evidence & confidence

The higher target is based on expected cloud revenue acceleration and AI tailwinds.

$PATHBearishMedium confidence
Context

BofA lowered its price objective for UiPath (PATH) while raising targets for peers, indicating a relative weakness.

Expected impact

likely downward pressure as the lowered target signals weaker outlook.

Evidence & confidence

A reduced target suggests concerns about PATH's growth relative to peers.

Market effects

Infrastructure software may see broader rerating as AI demand is highlighted.

U.S. tech sector could benefit from heightened AI focus.

Global investors tracking AI‑enabled software may adjust exposure.

Counterpoint

Price targets may be overly optimistic given high current valuations and competitive pressure.

Key entities

  • BofA Securities

    Provider of the price‑target updates and sector outlook.

  • Datadog

    Observability platform with growing security revenue.

  • Atlassian

    Collaboration software benefiting from AI tailwinds.

  • UiPath

    Robotic process automation firm with a reduced target.

Related articles

$DDOGMed

Datadog valuation in focus as UBS lifts price target ahead of Q3 results

Datadog (DDOG) is set to report Q3 results on November 4. UBS raised its price target to $320, citing AI observability growth but warning of elevated valuation and mixed enterprise spending trends. Shares up 15% since Q2 results, trading at 17x 2027 revenue and 57x free cash flow. UBS notes potential upside from OpenAI spending but cautions on core revenue growth stabilization.

$DDOGMed

Datadog Soars 4% as Oppenheimer Lifts Price Target to $330 Ahead of Nov. 4 Earnings

Datadog (DDOG) shares rose 4% after Oppenheimer raised its price target to $330 and maintained an Outperform rating. This follows recent upgrades from Bernstein and BofA, with a consensus target now at $293. Management expects modest revenue growth, but the company has beaten estimates for three quarters. Investors await Nov. 4 earnings, which must show strong revenue and core business growth.